Isolated testicular metastasis as a rare manifestation of castration-resistant prostate cancer.
This case illustrates the importance of <sup>68</sup>Ga-PSMA PET/CT in detecting rare testicular metastases from prostate cancer, with the patient achieving undetectable PSA levels after surgery.
Where it sits
this study against the rest of the goserelin corpusSummary and findings
This case report describes a 65-year-old male with isolated testicular metastasis from prostate cancer detected by <sup>68</sup>Ga-PSMA PET/CT. The patient was maintained on goserelin depot and achieved complete biochemical remission by 6 weeks postoperatively. PSA levels decreased to undetectable levels (<0.1 ng/mL).
Abstract
Secondary testicular metastasis from prostate cancer is exceptionally rare. We report an isolated testicular recurrence detected by <sup>68</sup>Ga-PSMA PET/CT in a 65-year-old male with biochemical progression (PSA 2.5 ng/mL) during castration resistance. Conventional imaging was negative, but <sup>68</sup>Ga-PSMA PET/CT revealed a right testicular lesion (SUV<sub>max</sub> 21.8). Right radical inguinal orchiectomy confirmed metastatic Grade Group 5 prostate adenocarcinoma. Maintained on goserelin depot, the patient achieved complete biochemical remission by 6 weeks postoperatively, with an undetectable PSA (<0.1 ng/mL) and castrate testosterone (16 ng/dL). <sup>68</sup>Ga-PSMA PET/CT is crucial for uncovering occult atypical metastases, while radical orchiectomy provides essential cytoreduction and definitive histopathological diagnosis.
Background
Secondary testicular metastasis from prostate cancer is exceptionally rare, and conventional imaging often fails to detect such occurrences. Prior studies have highlighted the utility of <sup>68</sup>Ga-PSMA PET/CT in identifying atypical metastases. This case illustrates the importance of advanced imaging techniques in detecting isolated testicular metastasis in patients with biochemical progression during castration resistance.
Methods
This is a case report involving a 65-year-old male with biochemical progression of prostate cancer. The patient underwent <sup>68</sup>Ga-PSMA PET/CT imaging, which revealed a right testicular lesion, and subsequently had a right radical inguinal orchiectomy. The primary outcome measured was the biochemical remission indicated by PSA levels post-surgery.
Results
The primary endpoint observed was an undetectable PSA level (<0.1 ng/mL) at 6 weeks postoperatively. The right testicular lesion was confirmed as metastatic Grade Group 5 prostate adenocarcinoma. The patient maintained on goserelin depot achieved castrate testosterone levels of 16 ng/dL.
Interpretation
This case adds to the limited literature on isolated testicular metastasis from prostate cancer, suggesting that advanced imaging can reveal atypical sites of metastasis. However, the clinical significance of the findings is limited by the small sample size and the nature of a single case report. The results imply that while goserelin may play a role in managing hormone levels, the evidence presented does not establish its efficacy in this specific context.
Key findings
- PSA 2.5 ng/mL at the time of detection.
- SUV<sub>max</sub> 21.8 for the right testicular lesion.
- Undetectable PSA (<0.1 ng/mL) at 6 weeks postoperatively.
- Castrate testosterone level of 16 ng/dL post-surgery.
Limitations
- Single case report limits generalizability.
- No statistical analysis provided.
- Short follow-up period of 6 weeks.
- No control group for comparison.